Further strengthening this assumption, Tanaka et al. [24] suggested a harmful effect of PD-L1 expression in esophageal cancer patients receiving neoadjuvant chemotherapy that was not also noted in patients not receiving neoadjuvant chemotherapy. This evidence concerns the gene CD274 and esophageal cancer.